We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ENVB market cap is 817.31k. The company's latest EPS is USD -25.2086 and P/E is -0.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.45M | -2.38M | -2.48M | -1.9M | -2.08M |
| Net Income | -2.82M | -3.44M | -2.46M | -1.88M | -2.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 39.92M | 0 | 0 | 0 | 0 |
| Operating Income | -6.32M | -5.62M | -25.95M | -27.42M | -16.45M |
| Net Income | -6.03M | -6.87M | -48.98M | -18.8M | -17.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.62M | 4.3M | 8.85M | 6.05M | 4.79M |
| Total Liabilities | 4.18M | 2.34M | 2.37M | 646k | 839k |
| Total Equity | 2.44M | 1.96M | 6.48M | 5.41M | 3.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.01M | 4.1M | 26.72M | 19.55M | 4.3M |
| Total Liabilities | 14.38M | 681k | 4.41M | 4M | 2.34M |
| Total Equity | 10.62M | 3.42M | 22.31M | 14.67M | 1.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.34M | -14.1M | -2.6M | -5.49M | -6.42M |
| Investing | 12k | 12k | N/A | N/A | N/A |
| Financing | -1.16M | -1.34M | 6.66M | 6.69M | 7.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.45M | -3.89M | -11.46M | -17.15M | -14.1M |
| Investing | -284k | -44k | 2.19M | -584k | 12k |
| Financing | 1.8M | 5.53M | 24.9M | 18.18M | -1.34M |
| Market Cap | 817.31k |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.36 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 692.58k |
| Average Volume (1 week) | 284.64k |
| Average Volume (1 Month) | 606.69k |
| 52 Week Change | -91.35% |
| 52 Week High | 43.80 |
| 52 Week Low | 1.13 |
| Spread (Intraday) | 0.03 (2.48%) |
| Company Name | Enveric Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.enveric.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
